Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 7;326(21):2203-2204.
doi: 10.1001/jama.2021.19885.

Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years

Noa Eliakim-Raz  1 , Yaara Leibovici-Weisman  1 , Amos Stemmer  2 , Asaf Ness  1 , Muhammad Awwad  1 , Nassem Ghantous  1 , Salomon M Stemmer  1
Affiliations

Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years

Noa Eliakim-Raz et al. JAMA. .

Abstract

This study assesses antispike (anti-S) IgG antibody titers before and after a third BNT162b2 dose (booster) in individuals aged 60 years and older in Israel.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr S. M. Stemmer reported receiving research grants (to his institution) from CAN-FITE, AstraZeneca, BioLineRX, BMS, Clovis Oncology, CTG Pharma, Exelixis, GEICAM, Halozyme, Incyte, Lilly, Moderna, Teva Pharmaceuticals, and Roche and owning stocks and options in CTG Pharma, DocBoxMD, TyrNovo, VYPE, Cytora, and CAN-FITE. No other disclosures were reported.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Walsh EE, Frenck RW Jr, Falsey AR, et al. . Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med. 2020;383(25):2439-2450. doi:10.1056/NEJMoa2027906 - DOI - PMC - PubMed
    1. Levin EG, Lustig Y, Cohen C, et al. . Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N Engl J Med. Published online October 6, 2021. doi:10.1056/NEJMoa2114583 - DOI - PMC - PubMed
    1. Benotmane I, Gautier G, Perrin P, et al. . Antibody response after a third dose of the MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses. JAMA. 2021;326(11):1063-1065. doi:10.1001/jama.2021.12339 - DOI - PMC - PubMed
    1. Bar-On YM, Goldberg Y, Mandel M, et al. . Protection of BNT162b2 vaccine booster against Covid-19 in Israel. N Engl J Med. 2021;385(15):1393-1400. doi:10.1056/NEJMoa2114255 - DOI - PMC - PubMed
    1. Harvey RA, Rassen JA, Kabelac CA, et al. . Association of SARS-CoV-2 seropositive antibody test with risk of future infection. JAMA Intern Med. 2021;181(5):672-679. doi:10.1001/jamainternmed.2021.0366 - DOI - PMC - PubMed

MeSH terms